It has been suggested that ASF1B overexpression promotes tumor progression and metastasis in several cancers, such as breast cancer (52), cervical cancer (53), clear cell renal cell carcinoma (54), and prostate cancer (55). Here, ASF1B is linked to cervical carcinoma.